CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) at Dr. Essa Lab

CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) at Dr. Essa Lab

The CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) at Dr. Essa Lab is a highly specialized, minimally invasive interventional radiology procedure designed to obtain precise tissue samples from deep-seated lesions within the human body. By utilizing state-of-the-art computed tomography (CT) imaging, our expert interventional radiologists can visualize internal anatomical structures in real-time, cross-sectional detail. This exceptional imaging capability allows the physician to map a precise trajectory for the biopsy needle, avoiding vital structures such as major blood vessels, nerves, and adjacent organs. This procedure is critical for establishing a definitive histopathological diagnosis, which is the gold standard for guiding oncological, infectious, and inflammatory treatment pathways.

Computed tomography works by emitting a series of narrow X-ray beams as it rotates around the patient, generating detailed digital slices of the target area. During a CT-guided biopsy, these images are used to confirm the exact location, size, and depth of an abnormal mass, nodule, or fluid collection. The designation ‘WITHOUT NEEDLE CHARGES’ indicates that the procedural fee covers the advanced CT imaging guidance, the clinical expertise of the interventional team, local anesthesia, and facility utilization, while the specialized biopsy needle itself is sourced or billed separately based on the specific gauge, length, and design required for the target tissue. This approach ensures that patients only pay for the exact medical consumables required for their unique anatomical needs.

This diagnostic intervention is highly valued across multiple medical specialties, including oncology, pulmonology, gastroenterology, urology, and internal medicine. It provides a safer, more comfortable, and significantly less invasive alternative to open surgical biopsies, requiring only local anesthesia and a brief post-procedure observation period. The tissue samples retrieved are subsequently processed by the pathology department at Dr. Essa Lab, where expert pathologists perform microscopic examination, immunohistochemistry, and molecular profiling to deliver an accurate and actionable diagnosis.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure patient safety and the diagnostic success of the CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) at Dr. Essa Lab. Patients must adhere to the following clinical guidelines prior to the procedure:

• Coagulation Profile: Patients must undergo blood tests, including Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT), within one week of the procedure to assess blood clotting function and minimize bleeding risks.
• Medication Review: Patients must inform the clinical team of all medications they are currently taking. Blood thinners, anticoagulants (such as Warfarin, Heparin, or Clopidogrel), and non-steroidal anti-inflammatory drugs (NSAIDs like Aspirin or Ibuprofen) must typically be discontinued several days prior to the biopsy, strictly under the guidance of the prescribing physician.
• Fasting Requirements: Patients are generally required to fast (no solid food or liquids) for 4 to 6 hours before the scheduled procedure to mitigate the risk of aspiration and prepare for potential conscious sedation if required.
• Medical History and Prior Imaging: It is mandatory to bring all previous diagnostic reports, including prior CT scans, MRI reports, PET scans, and relevant laboratory results, to assist the interventional radiologist in planning the procedure.
• Accompanying Companion: Because local anesthesia and potential mild sedation are administered, patients must arrange for a responsible adult companion to accompany them home after the procedure.

During the Procedure

The CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) is performed in a dedicated interventional CT suite under strict sterile conditions. The step-by-step clinical process includes:

• Patient Positioning: The patient is positioned on the CT scanner table in a prone, supine, or lateral decubitus position, depending on the anatomical location of the target lesion. Comfort is prioritized to ensure the patient remains completely still during the scan.
• Localization Scan: A preliminary ‘scout’ CT scan is performed to identify the precise coordinates of the lesion. The radiologist marks the optimal entry point on the patient’s skin.
• Aseptic Preparation and Anesthesia: The skin at the insertion site is thoroughly cleansed with an antiseptic solution and covered with sterile drapes. A local anesthetic (typically lidocaine) is injected into the skin and subcutaneous tissues to numb the area, minimizing discomfort.
• Needle Insertion under CT Guidance: The interventional radiologist makes a tiny incision (1-2 mm) in the skin. Using intermittent CT scans to monitor progress, the radiologist carefully advances the biopsy needle toward the target lesion. The ‘WITHOUT NEEDLE CHARGES’ protocol allows the radiologist to utilize the most appropriate needle type (such as a coaxial core needle or fine-needle aspiration system) selected for the patient’s specific tissue type.
• Specimen Collection: Once the needle tip is accurately positioned within the lesion, the radiologist collects multiple tissue cores or fluid aspirates. The patient may feel a brief sensation of pressure or a clicking sound as the biopsy device is activated.
• Post-Procedure Care: The needle is withdrawn, and firm manual pressure is applied to the site to prevent bleeding. A sterile dressing is applied. The patient is monitored in a recovery area for 2 to 4 hours, during which vital signs are checked regularly. For lung biopsies, a post-procedure chest X-ray is routinely performed to rule out pneumothorax.

When is a CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) Performed?

Evaluation of Suspected Pulmonary Nodules or Masses

Physicians frequently request a CT-guided lung biopsy when a routine chest X-ray or diagnostic CT scan reveals an unexplained pulmonary nodule, solitary mass, or mediastinal lesion. This procedure is crucial when the lesion is located in the peripheral lung parenchyma, making it inaccessible via standard bronchoscopy. The biopsy helps differentiate between primary lung malignancies (such as adenocarcinoma or squamous cell carcinoma), metastatic disease from other primary sites, and benign infectious processes like tuberculosis or fungal granulomas.

Characterization of Hepatic or Pancreatic Lesions

In patients presenting with focal liver lesions, atypical hemangiomas, or pancreatic masses detected on ultrasound or contrast-enhanced imaging, a CT-guided biopsy is performed to obtain tissue for definitive diagnosis. This is particularly important for patients with underlying cirrhosis where hepatocellular carcinoma is suspected, or in cases where a pancreatic mass must be histologically confirmed as ductal adenocarcinoma before initiating chemotherapy, radiation, or surgical resection (Whipple procedure).

Investigation of Renal Masses and Retroperitoneal Tumors

When imaging identifies solid renal masses, complex cystic lesions, or retroperitoneal soft tissue masses, a CT-guided biopsy provides the necessary tissue to distinguish between renal cell carcinoma, oncocytoma, retroperitoneal sarcoma, or metastatic disease. This assists urologists and oncologists in planning organ-sparing surgeries or systemic therapies, avoiding unnecessary radical nephrectomies for benign lesions.

Diagnosis of Unexplained Bone or Soft Tissue Lesions

Musculoskeletal oncologists and rheumatologists utilize CT-guided biopsies to evaluate osteolytic, osteoblastic, or deep-seated soft tissue masses that are highly suspicious for primary bone sarcomas, metastatic bone disease, or infectious osteomyelitis. The high-resolution CT guidance allows the needle to penetrate cortical bone defects precisely, obtaining diagnostic marrow and stromal tissue without causing pathological fractures.

Assessment of Deep-Seated Lymphadenopathy or Pelvic Masses

Enlarged lymph nodes within the retroperitoneum, pelvis, or deep abdomen that are inaccessible by physical examination or superficial ultrasound are prime candidates for CT-guided biopsy. This intervention is essential for diagnosing hematological malignancies such as Hodgkin and Non-Hodgkin lymphoma, as well as staging pelvic malignancies originating from the gynecological or genitourinary tracts.

What Does a CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) Detect?

The histopathological and cytological analysis of specimens obtained via CT-guided biopsy can detect a wide range of benign, infectious, inflammatory, and malignant conditions, including:

• Adenocarcinoma: A common malignant epithelial tumor frequently detected in the lungs, pancreas, and gastrointestinal tract.
• Squamous Cell Carcinoma: A malignant neoplasm arising from squamous epithelium, commonly found in the lungs and cervix.
• Small Cell Lung Carcinoma: A highly aggressive neuroendocrine tumor of the lung requiring rapid oncological intervention.
• Hepatocellular Carcinoma: Primary liver cancer arising from hepatocytes, often associated with chronic hepatitis or cirrhosis.
• Metastatic Carcinoma: Secondary tumor deposits in organs like the liver, lungs, or bones, originating from primary cancers elsewhere.
• Renal Cell Carcinoma: Malignant tumors originating from the renal tubular epithelium.
• Pancreatic Ductal Adenocarcinoma: The most common malignant neoplasm of the pancreas.
• Hodgkin Lymphoma: A hematological malignancy characterized by the presence of Reed-Sternberg cells in lymph node biopsies.
• Non-Hodgkin Lymphoma: A diverse group of blood cancers affecting lymphoid tissues.
• Tuberculosis Granuloma: Chronic inflammatory lesions characterized by caseating necrosis, indicative of Mycobacterium tuberculosis infection.
• Fungal Infections: Conditions such as aspergillosis, histoplasmosis, or coccidioidomycosis presenting as pulmonary nodules.
• Sarcoidosis: A systemic inflammatory disease characterized by non-caseating granulomas in multiple organs.
• Pyogenic Abscess: Localized collections of pus caused by bacterial infections within the liver, kidneys, or soft tissues.
• Hepatic Hemangioma: A benign vascular liver lesion that may occasionally require biopsy to rule out malignancy.
• Focal Nodular Hyperplasia: A benign, regenerative liver lesion.
• Renal Oncocytoma: A benign renal epithelial tumor that closely mimics renal cell carcinoma on imaging.
• Retroperitoneal Liposarcoma: A rare, malignant tumor arising from deep fat cells in the retroperitoneum.
• Leiomyosarcoma: A malignant smooth muscle tumor that can develop in the retroperitoneum or pelvic cavity.
• Osteosarcoma: A primary malignant bone tumor characterized by the production of osteoid.
• Ewing Sarcoma: A highly malignant round cell bone tumor primarily affecting children and young adults.
• Osteomyelitis: A bacterial or fungal infection of the bone and bone marrow.
• Fibrous Dysplasia: A benign bone condition where normal bone is replaced with fibrous connective tissue.
• Chronic Interstitial Nephritis: An inflammatory kidney condition affecting the interstitium and tubules.
• Benign Simple Cysts: Non-cancerous fluid-filled structures in organs like the kidneys or liver.
• Atypical Hyperplasia: Pre-cancerous cellular changes that require close clinical surveillance or surgical excision.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for biopsy results can be an anxious time for patients and their families. The diagnostic process involves two main phases: the interventional procedure and the subsequent pathological analysis. The preliminary radiology report documenting the successful placement of the needle and the absence of immediate post-procedure complications is generated shortly after the biopsy is completed.

The tissue specimens are immediately transferred to our state-of-the-art pathology laboratory. Standard histopathological processing, including tissue fixing, paraffin embedding, sectioning, and hematoxylin and eosin (H&E) staining, typically takes 3 to 5 working days. If specialized immunohistochemical (IHC) stains or molecular testing (such as EGFR, ALK, or PD-L1 profiling for lung cancers) are required to establish a precise diagnosis, the final report may take 7 to 10 working days. Dr. Essa Lab offers convenient digital report access. Patients can securely view, download, and print their diagnostic reports through our official online portal and mobile application, or collect physical copies from any of our diagnostic centers across Karachi and Pakistan.

CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lung Parenchyma	Normal alveolar architecture, thin-walled septa, no cellular atypia.	Bronchogenic carcinoma, granulomatous inflammation (TB), organizing pneumonia.
Hepatic Tissue	Normal cords of hepatocytes, preserved portal triads, no fibrosis.	Hepatocellular carcinoma, metastatic adenocarcinoma, hepatic steatosis, cirrhosis.
Renal Parenchyma	Normal glomeruli, tubules, and interstitial tissue.	Renal cell carcinoma, oncocytoma, chronic interstitial nephritis.
Pancreatic Tissue	Normal acinar cells and ductal epithelium.	Pancreatic ductal adenocarcinoma, neuroendocrine tumor, chronic pancreatitis.
Lymph Nodes	Normal lymphoid follicles, preserved sinus architecture.	Hodgkin or Non-Hodgkin lymphoma, metastatic deposits, reactive hyperplasia.
Bone & Skeletal Structure	Normal trabecular bone, active hematopoietic marrow.	Osteosarcoma, metastatic osteolytic lesions, pyogenic osteomyelitis.
Retroperitoneal Soft Tissue	Normal mature adipose tissue, fibrous tissue, and skeletal muscle.	Liposarcoma, leiomyosarcoma, retroperitoneal fibrosis, benign lipoma.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for CT SCAN GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) (DELDC)?

• Established Legacy: Serving patients since 1987 with a reputation for diagnostic excellence and trust across Pakistan.
• Expert Interventional Radiologists: Procedures are performed by highly trained and experienced interventional radiologists specializing in image-guided procedures.
• Advanced CT Technology: Equipped with modern, high-resolution multi-slice CT scanners that ensure maximum precision and patient safety.
• Integrated Pathology Services: Biopsy specimens are analyzed in-house by expert pathologists, ensuring seamless coordination and rapid turnaround times.
• Patient-Focused Care: Dedicated clinical staff provide compassionate care, thorough pre-procedure counseling, and attentive post-procedure monitoring.
• Strict Safety Protocols: Adherence to international sterilization and radiation safety standards to minimize risks and complications.
• Convenient Online Portal: Easy access to digital reports and imaging files through our secure online portal and mobile app.
• Widespread Network: Conveniently located diagnostic centers across Karachi and other major cities, making high-quality healthcare accessible.